Ameriprise’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-115,450
Closed -$19.1M 4021
2021
Q2
$19.1M Sell
115,450
-46,245
-29% -$7.64M 0.01% 1397
2021
Q1
$24.8M Sell
161,695
-311,966
-66% -$47.8M 0.01% 1167
2020
Q4
$59.4M Sell
473,661
-25,016
-5% -$3.14M 0.02% 667
2020
Q3
$50.6M Sell
498,677
-451,191
-48% -$45.8M 0.02% 637
2020
Q2
$92.4M Sell
949,868
-46,127
-5% -$4.49M 0.04% 415
2020
Q1
$82.7M Sell
995,995
-222,259
-18% -$18.5M 0.04% 385
2019
Q4
$135M Buy
1,218,254
+281,642
+30% +$31.3M 0.06% 323
2019
Q3
$92.9M Sell
936,612
-52,556
-5% -$5.22M 0.04% 429
2019
Q2
$98.1M Buy
989,168
+289,416
+41% +$28.7M 0.04% 429
2019
Q1
$77.2M Sell
699,752
-58,077
-8% -$6.41M 0.04% 494
2018
Q4
$69.7M Sell
757,829
-473,677
-38% -$43.6M 0.03% 500
2018
Q3
$136M Sell
1,231,506
-361,528
-23% -$39.9M 0.05% 363
2018
Q2
$149M Buy
1,593,034
+19,184
+1% +$1.79M 0.07% 302
2018
Q1
$131M Buy
1,573,850
+736,432
+88% +$61.1M 0.06% 314
2017
Q4
$76.3M Buy
837,418
+3,384
+0.4% +$308K 0.03% 443
2017
Q3
$63.5M Buy
834,034
+45,227
+6% +$3.44M 0.03% 489
2017
Q2
$59.2M Buy
788,807
+147,428
+23% +$11.1M 0.03% 499
2017
Q1
$41.8M Buy
641,379
+429,621
+203% +$28M 0.02% 611
2016
Q4
$11.7M Buy
211,758
+44,778
+27% +$2.47M 0.01% 1412
2016
Q3
$9.44M Buy
166,980
+18,124
+12% +$1.02M 0.01% 1497
2016
Q2
$6.22M Sell
148,856
-54,044
-27% -$2.26M ﹤0.01% 1769
2016
Q1
$8.68M Buy
+202,900
New +$8.68M 0.01% 1539